EMA Biosimilars
Jul 04, 2014
EMA Biosimilars Approvals
In the European Union (EU), a legal framework for approving biosimilars was established in 2003. This framework means that biosimilars can only be approved centrally via the European Medicines Agency (EMA) and not nationally. On 27 June 2014, the European Medicines Agency’s (EMA’s) Committee for Medicinal Produc...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
